Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Daily Burden of CRSwNP

Daily Burden of CRSwNP

Atopic Dermatitis Pathophysiology: Breaking Down the Barrier

Atopic Dermatitis Pathophysiology: Breaking Down the Barrier

EOE Pediatric - Unmasking the Hidden Symptoms

EOE Pediatric - Unmasking the Hidden Symptoms

Importance of assessing key disease domains in EOE

Importance of assessing key disease domains in EOE

Airway Hyperresponsiveness<br/>in Asthma

Airway Hyperresponsiveness
in Asthma

Cardiovascular Disease in Saudi Arabia: Facts and the Way Forward

Cardiovascular Disease in Saudi Arabia: Facts and the Way Forward

Uncover ASMD and GAUCHER

Uncover ASMD and GAUCHER

Approach for Patients with PAD and T2D: Focus on LDL-C Control

Approach for Patients with PAD and T2D: Focus on LDL-C Control

Approach for Patients with CAD: Focus on LDL-C Control

Approach for Patients with CAD: Focus on LDL-C Control

Cardiovascular diseases (CVDs) are the leading cause of death globally<sup>1</sup>

Cardiovascular diseases (CVDs) are the leading cause of death globally1

According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths1. Of these deaths, 85% were due to myocardial infarction or stroke1.

A CV event is a highly traumatic experience for patients and their families2. It takes a heavy emotional toll, brings widespread disability and significantly impedes quality of life3,4.

Flu and Vaccination

Flu and Vaccination

Flu and Diabetes

Flu and Diabetes